Ignite Creation Date:
2025-12-25 @ 3:49 AM
Ignite Modification Date:
2026-01-12 @ 9:38 AM
Study NCT ID:
NCT03042702
Status:
COMPLETED
Last Update Posted:
2018-12-27
First Post:
2017-02-01
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Phase 2 Study of Kevetrin in Subjects With Ovarian Cancer
Sponsor:
Innovation Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-02-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-11-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-10
Completion Date Type:
ACTUAL
First Submit Date:
2017-02-01
First Submit QC Date:
None
Study First Post Date:
2017-02-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-06
Results First Submit QC Date:
None
Results First Post Date:
2018-12-27
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-12-05
Last Update Post Date:
2018-12-27
Last Update Post Date Type:
ACTUAL